People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Dicerna Pharmaceuticals Inc | — | Biotechnology | Series C | $118.9M | $2.5B | 2010 |
David C. Madden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David C. Madden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan MacQuitty | 1 | 7 |
| Stephen Hoffman | 1 | 7 |
| Brian K. Halak | 1 | 5 |
| Dennis H. Langer | 1 | 3 |
| Dennis C. Langer | 1 | 2 |
| Peter K. Kolchinsky | 1 | 1 |
| Stephen K. Hoffman | 1 | 1 |
| David H. Madden | 1 | 1 |
| Jonathan H. MacQuitty | 1 | 1 |
| James C. Jenson | 1 | 1 |
| David K. Madden | 1 | 1 |
| Jonathan C. MacQuitty | 1 | 1 |
| Douglas Fambrough | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.